Meletios-Athanasios Dimopoulos

256PUBLICATIONS
481CO-AUTHORS
Medical mycologyMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (256)

|Jun 17, 2026
Prognostic value of <i>MYD88</i>/<i>CXCR4</i> mutation allele fraction in Waldenström macroglobulinemia using a multiplex ddPCR assay.

|May 04, 2026
Delving into tRNA-derived small RNAs in multiple myeloma: elevated 3'U-tRF<sup>SerTGA</sup> leads to poor disease prognosis.

|Apr 06, 2026
Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial.

Francesca Gay, Wilfried Roeloffzen, Meletios A Dimopoulos

|Apr 02, 2026
The Role of Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma With Renal Impairment: A Systematic Review.

Ioannis Ntanasis-Stathopoulos, Sotirios Manganas, Charalampos Filippatos

|Mar 27, 2026
Molecular Profiling and Treatment Outcomes in Uterine Serous Carcinoma: Prognostic Role of Estrogen Receptor Expression.

Anna Svarna, Michalis Liontos, Kallirroi Goula

|Mar 26, 2026
Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma.

Shaji Kumar, Sundar Jagannath, Katja C Weisel

Pageof 43

Frequent Collaborators

116 joint publications

Evangelos Terpos

98 joint publications

Kastritis Efstathios

84 joint publications

Ioannis Ntanasis-Stathopoulos

59 joint publications

Maria Gavriatopoulou